Skip to main content

Search

COVID 19 PLACES: ECUADOR

ecuador_place_slide.jpg

This essay supports an upcoming discussion of how COVID-19 is unfolding in Ecuador and a broader discussion within the Transnational STS COVID-19 project.

Shuar Testimony

This audio was sent by Manuel Maiche, community leader of Kuamar, part of the Shuar territory in Ecuador.

Ecuador Place Essay Image

Image created with the use of a free image by Crystal Mirallegro (Unsplash website) for Ecuador's covid19 place essay

Image with rainforest trees on background

Rhetoric Team Description

Ian Ferris describes the methods and focus of the Rhetoric Field Team of the Austin Anthropocene Field Campus.

pece_annotation_1473995548

tamar.rogoszinski
  1. I first looked up travel to and from Liberia during the Ebola outbreak, since it had been seized. There was a ban, which has since been lifted after, but people coming to and from West Africa are still screened and recommended to visit physicians. As of mid-2015 there wa still a 21 day monitoring period needed. http://www.infectioncontroltoday.com/news/2015/05/cdc-downgrades-travel…'
  2. I was interested if there had been any progress on treatment for Ebola, but found that the main form of treatment is supportive care. Doctors are informed to provide IV fluid and ensure that the patient's immune response and other bodily functions are functioning properly. A vaccine is being worked on but has not gone through a trial to prove safety and effectiveness. https://www.cdc.gov/vhf/ebola/treatment/index.html
  3. I looked further into the vaccine being produced for Ebola. Currently, there is a combined phase 2 and phase 3 trial occurring in Sierra Leone called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola). The study is unblinded, so patients know whether or not they have received the vaccine. The vaccine is a rVSV-ZEBOV, or recombinant Vesicular Stomatitis Virus Zaire ebolavirus vaccine. This vaccine is also being used in phase 2 and phase 3 trials in Guinea and Liberia http://www.cdc.gov/vhf/ebola/strive/qa.html